
        <!DOCTYPE html>
        <html>
        <head>
            <title>DexCom Inc. (DXCM) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">DexCom Inc. (DXCM)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">44</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">18</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">15</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.07</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d4ad8d6061a012b3811e7bb20b75355b6afb9bb2180fbb1a177516c32b0101a9" target="_blank" rel="noopener noreferrer">Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.94
                                </span>
                            </div>
                            <div class="article-summary">The major averages were sharply lower near noon, curtailing some of yesterday’s sharp gains after President Donald Trump announced a 90-day pause on some of his “reciprocal” tariffs, despite announcin...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4898c0093c6bedc0ff9a98a106ae95641f51b2018ea63c483682d5b2f0e9fb62" target="_blank" rel="noopener noreferrer">DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience and expanding diabetes care access....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0b0021f636c38990940d432189979aeaf8fe98c1af38dd44c696d9c4d1bd676e" target="_blank" rel="noopener noreferrer">DexCom Shares Rise in Premarket on FDA Clearance for Glucose Monitoring System</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.85
                                </span>
                            </div>
                            <div class="article-summary">DexCom Shares Rise in Premarket on FDA Clearance for Glucose Monitoring System...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0cceaa6718facf75456b9d1e8f9373c9fea193ef6d71eccca134064b1122ac8d" target="_blank" rel="noopener noreferrer">Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.79
                                </span>
                            </div>
                            <div class="article-summary">SAN DIEGO, April 10, 2025--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5a0e7c0744b919a7585622b21a8490f941a1fb65f97db4baba7ccb35975c33fc" target="_blank" rel="noopener noreferrer">Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.91
                                </span>
                            </div>
                            <div class="article-summary">Dexcom stock surged Thursday after the Food and Drug Administration cleared its newest diabetes device for an extended 15-day period....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1162191fd5d694f0b0066f177b9f1a4c2c22cb0cacfe3b272fced46fe802fadb" target="_blank" rel="noopener noreferrer">Dexcom nets FDA clearance for 15-day CGM</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">The longer wear time should improve Dexcom’s margins and help it compete with Abbott, RBC Capital Markets analyst Shagun Singh said....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5758b29ab168a38577edb4c643aa9df14a2dff74714d2a3ed10e130164ac634e" target="_blank" rel="noopener noreferrer">2 Growth Stocks to Buy in the Tariff-Fueled Market Correction</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">For those who can afford it without blowing their budget, it's actually a great idea to pick up shares of top companies on the dip during a correction.  With that in mind, here are two excellent growt...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5fa5a940b7bceabe3e74436e115fd61f972dc0605b0034e5d8b90e5101c613fb" target="_blank" rel="noopener noreferrer">DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.89
                                </span>
                            </div>
                            <div class="article-summary">DexCom  stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food and Drug Administration for a new glucose monitoring system.  Shares of t...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b21ef1ec4782e7c2dfb50c7e23d55d0ea063f3802fdd365ea54bcfd3bbd886f8" target="_blank" rel="noopener noreferrer">FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute Relati...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a4f1fe7766d7f826d16900557c070b67f75007774862e57868b964313f5b4819" target="_blank" rel="noopener noreferrer">FDA Approves New DexCom Diabetes Device</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.71
                                </span>
                            </div>
                            <div class="article-summary">The Food and Drug Administration has cleared diabetes-management firm DexCom's new continuous glucose monitoring (CGM) system....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=60bcbe2f32264d2efec6f1b2ebcc84c6422898821569395283307b76cf3871ba" target="_blank" rel="noopener noreferrer">DexCom Inc. stock outperforms competitors on strong trading day</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-09</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">DexCom Inc. stock outperforms competitors on strong trading day...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f5f007508423ecc6a6ed2809e7629f4fa815a2202213d5a4045b0d02138f7e9f" target="_blank" rel="noopener noreferrer">Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bda3935de280f7950bdb6884dc8f0aedeac540cabf75866aac2d95e6818a6d79" target="_blank" rel="noopener noreferrer">DexCom Inc. stock underperforms Tuesday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-08</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.92
                                </span>
                            </div>
                            <div class="article-summary">DexCom Inc. stock underperforms Tuesday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3e712f7630de9f287555d0df409eb7ba1334aa95e7c99e5f4186361ee78037bb" target="_blank" rel="noopener noreferrer">DexCom (NasdaqGS:DXCM) Down 12% As Jon Coleman Becomes Chief Commercial Officer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.94
                                </span>
                            </div>
                            <div class="article-summary">DexCom (NasdaqGS:DXCM) experienced an 12% decline over the past week, during which the company transitioned its audit from Ernst & Young to Deloitte & Touche, and appointed Jon Coleman as Chief Commer...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6ba1edab32091b9d5d15de726b07a143a4217f8052414acaa931f82906b0b29a" target="_blank" rel="noopener noreferrer">Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4: 30 p.m. Eastern Time</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-04</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">SAN DIEGO - DexCom, Inc. today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 1, 2025.Management will hold a conference call to......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=baf24f7122b59249eab3e61251a9f3d4fe5da4a2212f3107c8a5157f120ef27a" target="_blank" rel="noopener noreferrer">Here's Why You Should Retain DexCom Stock in Your Portfolio for Now</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">DXCM continues to raise investor optimism due to its strong product portfolio....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=de4013c55290d4ec7294a25f19cdc25e3ed1fe89f8db9e109c1294cc37598ba6" target="_blank" rel="noopener noreferrer">DexCom Inc. stock outperforms competitors despite losses on the day</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-04</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">DexCom Inc. stock outperforms competitors despite losses on the day...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=52f980e081eccc54f97e83f1f5a96dbbfe076e8fcc407180cc9438f9f331dc76" target="_blank" rel="noopener noreferrer">Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4: 30 p.m. Eastern Time.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-03</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">DexCom, Inc. today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 1, 2025. Management will hold a conference call to review the......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bdf984d09b947cf770e23ad82331a0aca76c269b01ddfad1193f5b26790cee3b" target="_blank" rel="noopener noreferrer">Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.54
                                </span>
                            </div>
                            <div class="article-summary">Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e3a7e78e3ca9eb636063de84bf2bcc8b38f308dfde2e9c6e85a4f571ffb1d311" target="_blank" rel="noopener noreferrer">Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">SAN DIEGO, April 03, 2025--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 1, 2025. Management will hol...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e493bfc8fffa7cd40af8a17ea8a8830716ea81e4055640d3f3122afcc538eed1" target="_blank" rel="noopener noreferrer">DexCom Inc. stock underperforms Thursday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-03</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.93
                                </span>
                            </div>
                            <div class="article-summary">DexCom Inc. stock underperforms Thursday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7f9fca4aacfd528148473d4667023476d3a27d46fc669d0b8e4d038a586eacc8" target="_blank" rel="noopener noreferrer">Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.79
                                </span>
                            </div>
                            <div class="article-summary">BURNABY, British Columbia, April 01, 2025--The Government of Saskatchewan expands public coverage for Dexcom Continuous Glucose Monitoring Systems....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b48a59017dd12e9c177c1efa4c195c8c6e98a32c8fbb7d0a913707e5da1c0127" target="_blank" rel="noopener noreferrer">DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.39
                                </span>
                            </div>
                            <div class="article-summary">Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A copy of the same can be downloaded here. Select Growth primarily targets U.S...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e7f3a2fdeb4469d28849be47beed22d90075a78169bb5d09db9dc63c39b3ef88" target="_blank" rel="noopener noreferrer">DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.91
                                </span>
                            </div>
                            <div class="article-summary">DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic health monitoring....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5cb18435ede04f6f2735d872fd612ecef3de09629588b04c99183869b77c31a6" target="_blank" rel="noopener noreferrer">These 20 worst-performing stocks in the S&P 500 sank 17% or more in March</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-31</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.97
                                </span>
                            </div>
                            <div class="article-summary">These 20 worst-performing stocks in the S&P 500 sank 17% or more in March...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4426ea82fc54b5f5cd6711ee300e3ccafa4b900c35c4097b4dd1300d6e966829" target="_blank" rel="noopener noreferrer">Baird Q4 2024 Mid Cap Growth Strategy Commentary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-28</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">For the quarter, the Baird Mid Cap Growth portfolio produced a negative return of -1.3%, net of fees, trailing the Russell Midcap Growth increase of +8.1%....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9fb63d09aa8a0b4081633a73bc8ddfe1cd8b10ab0b3cff5319a51cd73d27b110" target="_blank" rel="noopener noreferrer">DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.96
                                </span>
                            </div>
                            <div class="article-summary">DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The company response is inadequate....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4a07cc01e85ecff03ada7c03701a0f24dee3a668a266eb6de8ea3c1b349052d9" target="_blank" rel="noopener noreferrer">Dexcom rejects claims of unauthorized device changes in FDA warning letter</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.23
                                </span>
                            </div>
                            <div class="article-summary">A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its glucose sensors....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f73dabb9cfdd759108768afe3163e709a487767c55d75453d76bb306cf1cf3b3" target="_blank" rel="noopener noreferrer">DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-26</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.87
                                </span>
                            </div>
                            <div class="article-summary">DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost competitive advantage....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e8a5c64a8bc3004f7a618403eff86235997b0154e871e47ff0ef75df49142158" target="_blank" rel="noopener noreferrer">Dexcom’s FDA warning letter reveals unauthorized changes to sensors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-26</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.54
                                </span>
                            </div>
                            <div class="article-summary">Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, according to the warning letter....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=315d2f323ee828a07d49f8d73bf23c021320faccb78f6d9793e9085343b8ec9f" target="_blank" rel="noopener noreferrer">DexCom Inc. stock underperforms Wednesday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-26</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.94
                                </span>
                            </div>
                            <div class="article-summary">DexCom Inc. stock underperforms Wednesday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5977d7aef25a93615e2bc6df2e5fc699baa19f2ef50d3ff9f08c24de6bbba9e7" target="_blank" rel="noopener noreferrer">DexCom (NasdaqGS:DXCM) Expands Wearable Integration and Appoints New Chief Commercial Officer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-26</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">DexCom (NasdaqGS:DXCM) witnessed a 4% increase in its share price over the past week, as the company announced a significant integration of its G7 Continuous Glucose Monitoring Systems with Nanowear's...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=48d65a04f36c0f571abea4c15b35c47b9fa3c0388751715ac754d90b87ff11cb" target="_blank" rel="noopener noreferrer">Dexcom COO on 15-day glucose sensor, Type 2 coverage</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b894103d8877f1fa2b75b7fc7d13d7ee21605fbcf6afdde0cc4629551e31fee6" target="_blank" rel="noopener noreferrer">Dexcom Appoints Jon Coleman as Chief Commercial Officer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">SAN DIEGO, March 25, 2025--Dexcom Appoints Jon Coleman as Chief Commercial Officer...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3781ce9c064bf121677702a09894699028d09fb49b46bb0c0b1d019435b8648d" target="_blank" rel="noopener noreferrer">DexCom (DXCM): 3 Reasons We Love This Stock</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up might have investors contemplating their next mo...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=35aea9b0330b2fa00aed04ca73b9a9d65be73c2643bc35e4cfb54997a807b464" target="_blank" rel="noopener noreferrer">Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d189aaa8ce051b03a6ad26b5e037a1170befe7cf13714ef2d11c112556461346" target="_blank" rel="noopener noreferrer">DexCom Inc. stock underperforms Friday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-21</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.92
                                </span>
                            </div>
                            <div class="article-summary">DexCom Inc. stock underperforms Friday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4fe52f97df04873e83cfc46c5074e21da896d154ff19b7d9badfe4d08a2d32e7" target="_blank" rel="noopener noreferrer">3 Stocks That May Be Trading Below Estimated Value In March 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.32
                                </span>
                            </div>
                            <div class="article-summary">As the U.S. stock market navigates a period of mixed performance, with major indices like the Dow Jones and S&P 500 experiencing fluctuations amid economic uncertainties and tariff concerns, investors...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=dfa8afe56b93d52f923624a98ab0bfeeb55710e84829db01a74873bf13f494ed" target="_blank" rel="noopener noreferrer">Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">EDINBURGH, Scotland & SAN DIEGO, March 19, 2025--DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of T...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=989dc23fd50976f7c93b8d3b4525c25cd138e8d1acc996e1b49d20a19402920c" target="_blank" rel="noopener noreferrer">Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this.  Whatever happens, though, some stocks are still worth investing in and holding on to through marke...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bc217b0ee7921ffefe00e1d3a04d1e60e82f0718e53ef2fe44e90ad9117792f3" target="_blank" rel="noopener noreferrer">DexCom, Inc. (DXCM): Among the Best Diabetes Stocks to Buy According to Billionaires</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.32
                                </span>
                            </div>
                            <div class="article-summary">We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other best dia...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c529bffd46f67ad3b6e06aab77b7ef5ea9432c8a7274b59f030505a236cc5828" target="_blank" rel="noopener noreferrer">Abbott Laboratories Basking In A Sharp Turn In Sentiment</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-16</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.70
                                </span>
                            </div>
                            <div class="article-summary">Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes. Read why ABT stock is a Hold....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d5ef508fb28e6154539c73563ab22a6d23ca785038333b448046189cbfe47c47" target="_blank" rel="noopener noreferrer">History Says Shut Up And Buy: 12 Hyper-Growth Blue Chips To Buy Right Now</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-14</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Corrections often lead to robust recoveries, with historical returns averaging 25% in the year following severe volatility. Read about 10 stocks that can withstand the market swoons....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d5d19a028287e7838792063ac89f220eb01d06853b6b6254ed03021246b96c16" target="_blank" rel="noopener noreferrer">DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-03-14</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    -0.15
                                </span>
                            </div>
                            <div class="article-summary">DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising competition pose challenges....</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        